Luminist Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Luminist Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248	Buy	+1	New	+$215	﹤0.01%	389
2026 Q1	–	Sell	-1	Closed	-$207	–	152
2025 Q4	$207	Hold	1	–	–	﹤0.01%	266
2025 Q3	$185	Hold	1	–	–	﹤0.01%	326
2025 Q2	$162	Hold	1	–	–	﹤0.01%	334
2025 Q1	$164	Hold	1	–	–	﹤0.01%	242
2024 Q4	$166	Buy	+1	New	+$171	﹤0.01%	232

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Luminist Capital's FBT Position: Q2 2026 in Review

Luminist Capital opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 1 share worth $248. The stake represents ﹤0.01% of the portfolio and ranks #389 among its holdings. This is a return to the name: Luminist Capital previously reported a position in FBT as recently as Q4 2025.

Luminist Capital first reported a position in FBT in Q4 2024 and has held it in 6 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Luminist Capital held 1 share of First Trust NYSE Arca Biotechnology Index Fund worth $248 as of Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new Luminist Capital position in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Luminist Capital's portfolio in Q2 2026, its #389 holding.
Luminist Capital first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2024 and has held it in 6 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Luminist Capital's 13F filing for Q2 2026, filed 7 Aug 2026.